 Investigators will perform a baseline anti-3-18FFACBC PET-CT of the whole body. All participants will also undergo conventional staging including 99mTc MDP bone scanning and cat scan CT or magnetic resonance imaging MR of the abdomen and pelvis which are standard of care at the enrolling institution. This study will not interfere with standard patient evaluation or delay therapy. 